AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of GBP 254.15 billion. The enterprise value is 303.27 billion.

Market Cap	254.15B
Enterprise Value	303.27B

Important Dates

The last earnings date was Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	Apr 15, 2025

Share Statistics

Current Share Class	1.77B
Shares Outstanding	n/a
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.77B

Valuation Ratios

The trailing PE ratio is 79.03 and the forward PE ratio is 14.90.

PE Ratio	79.03
Forward PE	14.90
PS Ratio	5.72
PB Ratio	224.60
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.46, with an EV/FCF ratio of 25.47.

EV / Earnings	94.30
EV / Sales	6.98
EV / EBITDA	14.46
EV / EBIT	21.07
EV / FCF	25.47

Financial Position

The company has a current ratio of 0.76, with a Debt / Equity ratio of 47.90.

Current Ratio	0.76
Quick Ratio	0.48
Debt / Equity	47.90
Debt / EBITDA	2.53
Debt / FCF	4.55
Interest Coverage	6.68

Financial Efficiency

Return on equity (ROE) is 88.40% and return on invested capital (ROIC) is 15.45%.

Return on Equity (ROE)	88.40%
Return on Assets (ROA)	8.34%
Return on Invested Capital (ROIC)	15.45%
Return on Capital Employed (ROCE)	19.06%
Revenue Per Employee	807,300
Profits Per Employee	58,471
Employee Count	55,000
Asset Turnover	0.40
Inventory Turnover	3.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.27% in the last 52 weeks. The beta is 0.55, so AbbVie's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	+15.27%
50-Day Moving Average	196.67
200-Day Moving Average	189.43
Relative Strength Index (RSI)	52.55
Average Volume (20 Days)	30,448

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.50

Income Statement

In the last 12 months, AbbVie had revenue of GBP 44.40 billion and earned 3.22 billion in profits. Earnings per share was 1.81.

Revenue	44.40B
Gross Profit	31.53B
Operating Income	14.72B
Pretax Income	2.80B
Net Income	3.22B
EBITDA	21.18B
EBIT	14.72B
Earnings Per Share (EPS)	1.81

Full Income Statement

Balance Sheet

The company has 4.01 billion in cash and 54.20 billion in debt, giving a net cash position of -50.19 billion.

Cash & Cash Equivalents	4.01B
Total Debt	54.20B
Net Cash	-50.19B
Net Cash Per Share	n/a
Equity (Book Value)	1.13B
Book Value Per Share	0.62
Working Capital	-6.76B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 12.69 billion and capital expenditures -786.37 million, giving a free cash flow of 11.91 billion.

Operating Cash Flow	12.69B
Capital Expenditures	-786.37M
Free Cash Flow	11.91B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 71.01%, with operating and profit margins of 33.15% and 7.31%.

Gross Margin	71.01%
Operating Margin	33.15%
Pretax Margin	6.31%
Profit Margin	7.31%
EBITDA Margin	47.70%
EBIT Margin	33.15%
FCF Margin	26.82%

Dividends & Yields

This stock pays an annual dividend of 4.96, which amounts to a dividend yield of 2.66%.

Dividend Per Share	4.96
Dividend Yield	2.66%
Dividend Growth (YoY)	3.23%
Years of Dividend Growth	10
Payout Ratio	266.46%
Buyback Yield	-0.03%
Shareholder Yield	2.64%
Earnings Yield	1.27%
FCF Yield	4.69%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.14. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.14
Piotroski F-Score	n/a